GlassScriptPhysician profile
David M Davis
NPI 1023138625
$49,146.80
in general payments reported to CMS, 2019-2025
42 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,848 · 2022: $7,379 · 2023: $19K · 2024: $6,825 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,750 · Travel and Lodging: $4,591 · Consulting Fee: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,857.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,408.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,750.00 |
| Travel and Lodging | $4,590.63 |
| Consulting Fee | $313.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,968.17 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Biotronik Nro, INC. | $12,200.14 | 2023-2025 | Prospera, Biotronik |
| Tersera Therapeutics LLC | $2,163.07 | 2021-2025 | Prialt |
| Abbvie INC. | $2,108.61 | 2021-2025 | |
| Relievant Medsystems, INC. | $1,246.27 | 2023 | Intracept |
| Abbott Laboratories | $1,027.04 | 2021-2025 | Proclaim |
| Nevro Corp. | $835.22 | 2021-2023 | Senza |
| Saluda Medical Americas, INC. | $771.44 | 2023-2025 | Evoke Scs, Evoke |
| Vertex Pharmaceuticals Incorporated | $468.58 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $466.03 | 2021-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $458.49 | 2021-2025 | Belbuca, Xtampza |
| Amgen INC. | $457.64 | 2021-2022 | |
| Boston Scientific Corporation | $412.42 | 2021-2025 | Intracept, General - Pain Management |
| Painteq LLC | $391.88 | 2022-2023 | Painteq |
| Ibsa Pharma INC. | $361.39 | 2021-2025 | Tirosint, Licart, Tirosint |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $222.02 | 2021 | |
| Pfizer INC. | $200.89 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $173.82 | 2021-2023 | Ztlido |
| Almatica Pharma LLC | $169.82 | 2021-2023 | Gralise |
| Grt US Holding, INC. | $169.17 | 2021-2022 | |
| Radius Health, INC. | $164.96 | 2022 | |
| Azurity Pharmaceuticals, INC. | $163.87 | 2023-2025 | Horizant, Horizant |
| Spr Therapeutics, INC | $147.32 | 2023 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $142.76 | 2021 | |
| Globus Medical, INC. | $139.64 | 2025 | Senza |
| Vertos Medical, INC. | $138.46 | 2024 | Mild Device Kit |
| Lundbeck LLC | $128.37 | 2024-2025 | Vyepti |
| Lilly USA, LLC | $123.80 | 2022-2023 | Reyvow, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $123.12 | 2022 | |
| West Therapeutics Development, LLC | $103.97 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $90.26 | 2021-2022 | |
| Nalu Medical, INC. | $88.69 | 2023-2024 | Nalu Neurostimulation System |
| Mml US, INC. | $85.13 | 2025 | Reactiv8 |
| Stryker Corporation | $47.22 | 2021 | |
| Foundation Fusion Solutions, LLC | $38.58 | 2024 | |
| Fidia Pharma USA INC. | $38.28 | 2024-2025 | Hymovis, Hyalgan, Triluron |
| Arbor Pharmaceuticals, INC. | $36.83 | 2021 | |
| Allergan, INC. | $18.85 | 2021 | |
| Averitas Pharma INC. | $16.23 | 2023 | Qutenza |
| Tonix Medicines, INC. | $15.23 | 2025 | Tonmya |
| Horizon Therapeutics Plc | $14.45 | 2021 | |
| Forte Bio-Pharma LLC | $8.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.